1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Battula N, Madanur M, Priest O, Srinivasan
P, O'Grady J, Heneghan MA, Bowles M, Muiesan P, Heaton N and Rela
M: Spontaneous rupture of hepatocellular carcinoma: A Western
experience. Am J Surg. 197:164–167. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Okazaki M, Higashihara H, Koganemaru F,
Nakamura T, Kitsuki H, Hoashi T and Makuuchi M: Intraperitoneal
hemorrhage from hepatocellular carcinoma: Emergency
chemoembolization or embolization. Radiology. 180:647–651. 1991.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Sato Y, Fujiwara K, Furui S, Ogata I, Oka
Y, Hayashi S, Ohta Y, Iio M and Oka H: Benefit of transcatheter
arterial embolization for ruptured hepatocellular carcinoma
complicating liver cirrhosis. Gastroenterology. 89:157–159. 1985.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Corr P, Chan M, Lau WY and Metreweli C:
The role of hepatic arterial embolization in the management of
ruptured hepatocellular carcinoma. Clin Radiol. 48:163–165. 1993.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Xu HS and Yan JB: Conservative management
of spontaneous ruptured hepatocellular carcinoma. Am Surg.
60:629–633. 1994.PubMed/NCBI
|
7
|
Hsieh JS, Huang CJ, Huang YS, Sheen PC and
Huang TJ: Intraperitoneal hemorrhage due to spontaneous rupture of
hepatocellular carcinoma: Treatment by hepatic artery embolization.
AJR Am J Roentgenol. 149:715–717. 1987. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li WH, Cheuk EC, Kowk PC and Cheung MT:
Survival after transarterial embolization for spontaneous ruptured
hepatocellular carcinoma. J Hepatobihary Pancreat Surg. 16:508–512.
2009. View Article : Google Scholar
|
9
|
Yang T, Sun YF, Zhang J, Lau WY, Lai EC,
Lu JH, Shen F and Wu MC: Partial hepatectomy for ruptured
hepatocellular carcinoma. Br J Surg. 100:1071–1079. 2013.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Yeh CN, Lee WC, Jeng LB, Chen MF and Yu
MC: Spontaneous tumour rupture and prognosis in patients with
hepatocellular carcinoma. Br J Surg. 89:1125–1129. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cheung TT, Poon RT, Chok KS, Chan AC,
Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST and Lo CM: Management of
spontaneously ruptured hepatocellular carcinomas in the
radiofrequency ablation era. PLoS One. 9:e944532014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Toshikuni N, Takuma Y, Morimoto Y,
Shimomura H and Yamamoto H: Transarterial embolization for ruptured
hepatocellular carcinoma: Survival predictors.
Hepatogastroenterology. 58:565–569. 2011.PubMed/NCBI
|
13
|
Tan FL, Tan YM, Chung AY, Cheow PC, Chow
PK and Ooi LL: Factors affecting early mortality in spontaneous
rupture of hepatocellular carcinoma. ANZ J Surg. 76:448–452. 2006.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Kirikoshi H, Saito S, Yoneda M, Fujita K,
Mawatari H, Uchiyama T, Higurashi T, Imajo K, Sakaguchi T, Atsukawa
K, et al: Outcomes and factors influencing survival in cirrhotic
cases with spontaneous rupture of hepatocellular carcinoma: A
multicenter study. BMC Gastroenterol. 9:292009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kung CT, Liu BM, Ng SH, Lee TY, Cheng YF,
Chen MC and Ko SF: Transcatheter arterial embolization in the
emergency department for hemodynamic instability due to ruptured
hepatocellular carcinoma: Analysis of 167 cases. Am J Roentgenol.
191:W231–W239. 2008. View Article : Google Scholar
|
16
|
Lai EC and Lau WY: Spontaneous rupture of
hepatocellular carcinoma: A systematic review. Acta Radiol.
141:191–198. 2006.
|
17
|
Lau WY: Primary hepatocellular
carcinomaDisease of the Liver and Biliary Tract. Blumgart LH and
Fong Y: 3rd edition. WB Saunders Co, Ltd.; London, England: pp.
1423–1450. 2000
|
18
|
Zhang YW, Ao J, Liu Y, Qiao MX, Yang XL,
Tang SX, Li C and Xu K: Pharmacokinetics of gelatin sponge
microparticles in a rabbit VX2 liver tumor model of hepatic
arterial chemoembolization. Tumour Biol. 35:10905–10910. 2014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang YW and Liu Y: Transcatheter arterial
chemoembolization of hepatocellular carcinoma with 350-560 µm
gelatin sponge particles: Efficacy, tumour response and survival.
Zhonghua Gan Zang Bing Za Zhi. 21:637–638. 2013.(In Chinese).
PubMed/NCBI
|
20
|
Kamran AU, Liu Y, Li FE, Liu S, Wu JL and
Zhang YW: Transcatheter arterial chemoembolization with gelatin
sponge microparticles treated for BCLC stage B hepatocellular
carcinoma: A single center retrospective study. Medicine
(Baltimore). 94:e21542015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu Y, Zhang Y, Bautista D, Tang S, Zhou
J, Li C and Zhao G: Trans-arterial p53-gene-embolization with
gelatin sponge microparticles for hepatocellular carcinoma with
BCLC stage B: Single-centre experience. Cell Biochem Biophys.
71:99–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ramsey DE, Kernagis LY, Soulen MC and
Geschwind JF: Chemoembolization of hepatocellular carcinoma. J Vasc
Interv Radiol. 13:S211–S221. 2002. View Article : Google Scholar : PubMed/NCBI
|
23
|
World Health Organization, . Cancer Pain
Relief and Palliative Care. Report of a WHO Expert Committee;
Geneva: 1990, pp. 7–21
|
24
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Shin BS, Park MH and Jeon GS: Outcome and
prognostic factors of spontaneous ruptured hepatocellular carcinoma
treated with transarterial embolization. Acta Radiol. 52:331–335.
2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhu LX, Wang GS and Fan ST: Spontaneous
rupture of hepatocellular carcinoma. Br J Surg. 83:602–607. 1996.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Jin YJ, Lee JW, Park SW, Lee JI, Lee DH,
Kim YS, Cho SG, Jeon YS, Lee KY and Ahn SI: Survival outcome of
patients with spontaneously ruptured hepatocellular carcinoma
treated surgically or by transarterial embolization. World J
Gastroenterol. 19:4537–4544. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Liu CL, Fan ST, Lo CM, Tso WK, Poon RT,
Lam CM and Wong J: Management of spontaneous rupture of
hepatocellular carcinoma: Single-center experience. J Clin Oncol.
19:3725–3732. 2001.PubMed/NCBI
|
29
|
Tarantino L, Sordelli I, Calise F, Ripa C,
Perrotta M and Sperlongano P: Prognosis of patients with
spontaneous rupture of hepatocellular carcinoma in cirrhosis.
Updates Surg. 63:25–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Fujii M, Miyake H, Takamura K and Tashiro
S: Management of spontaneous ruptured hepatocellular carcinoma.
Nihon Geka Gakkai Zasshi. 105:292–295. 2004.(In Japanese).
PubMed/NCBI
|
31
|
Tanaka T, Yamanaka N, Oriyama T, Furukawa
K and Okamoto E: Factors regulating tumor pressure in
hepatocellular carcinoma and implications for tumor spread.
Hepatology. 26:283–287. 1997. View Article : Google Scholar : PubMed/NCBI
|
32
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Cammà C, Schepis F, Orlando A, Albanese M,
Shahied L, Trevisani F, Andreone P, Craxì A and Cottone M:
Transarterial chemoembolization for unresectable hepatocellular
carcinoma: Meta-analysis of randomized controlled trials.
Radiology. 224:47–54. 2002. View Article : Google Scholar : PubMed/NCBI
|
34
|
Kim YJ, Lee HG, Park JM, Lim YS, Chung MH,
Sung MS, Yoo WJ and Lim HW: Polyvinyl alcohol embolization adjuvant
to oily chemoembolization in advanced hepatocellular carcinoma with
arterioportal shunts. Korean J Radiol. 8:311–319. 2007. View Article : Google Scholar : PubMed/NCBI
|
35
|
Miyoshi A, Kitahara K, Kohya N, Noshiro H
and Miyazahi K: Outcomes of patients with spontaneous rupture of
hepatocellular carcinoma. Hepatogastroenterology. 58:99–102.
2011.PubMed/NCBI
|
36
|
Liu CL, Ngan H, Lo CM and Fan ST: Ruptured
hepatocellular carcinoma as a complication of transarterial oily
chemoembolization. Br J Surg. 85:512–514. 1998. View Article : Google Scholar : PubMed/NCBI
|
37
|
National Cancer Institute. Common
Terminology Criteria for Adverse Events (CTCAE) version 4. United
States Department of Health and Human Services. 2009, http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7pdfAccessed
February 22, 2012.
|